Pathological Reactions of Cytotoxic Lymphoid Cells as Universal Therapeutic Targets in Cancer and Autoimmune Disease

36.7K

views

70

authors

11

articles

Editorial

25 April 2023

Editorial: Pathological reactions of cytotoxic lymphoid cells as universal therapeutic targets in cancer and autoimmune disease

Vadim V. Sumbayev

,

Bernhard F. Gibbs

and

Elizaveta Fasler-Kan

907 views

1 citations

Editors

3

Elizaveta Fasler-Kan

University Hospital of Bern

Vadim V Sumbayev

University of Kent

Bernhard F. Gibbs

Canterbury Christ Church University

Impact

About

Malignant transformation of human cells is associated with the activation of immunosuppressive biochemical pathways, which allows them to escape immune surveillance. Cytotoxic lymphoid cells, mainly natural killer and T cells, are capable of attacking and eliminating malignant cells. There are several pathways that malignant cells can implement in order to create an immunosuppressive milieu and escape the immune attack, progressing in the disease.

On the other hand, a large number of individuals worldwide are affected by autoimmune disorders such as rheumatoid arthritis, psoriasis, multiple sclerosis, and many others. In autoimmune diseases, autoreactive T cells are considered as key players when acting as both regulatory and effector cells.

Based on the above, immunosuppressive biochemical pathways may become universal targets for immunotherapy in both human malignancies and autoimmune disorders. However, their targeting should lead to the opposite outcomes – downregulation in the case of cancer and activation in the case of autoimmunity.

The goal of this Research Topic is to provide recent advances in our understanding of the molecular and cellular mechanisms of anti-tumor immunity and autoimmune disease and, importantly, biochemical regulation and pharmacological correction of these immune networks.

We call for Original Research, Brief Research Reports, Reviews, Mini-Reviews, and Perspectives manuscripts that address the following topics:

• Recent advances in understanding the molecular mechanisms of anti-tumor immunity

• Novel findings related to tumour immune escape

• Novel approaches in anti-cancer immunotherapy

• Recent advances in understanding the mechanisms underlying autoimmune reactions

• Novel approaches for immunotherapy of autoimmune disease

• Key similarities and differences applicable to immunotherapy of cancer and autoimmune disease

• Pharmacological correction of immunosuppressive pathways

Malignant transformation of human cells is associated with the activation of immunosuppressive biochemical pathways, which allows them to escape immune surveillance. Cytotoxic lymphoid cells, mainly natural killer and T cells, are capable of attacking and eliminating malignant cells. There are several pathways that malignant cells can implement in order to create an immunosuppressive milieu and escape the immune attack, progressing in the disease.

On the other hand, a large number of individuals worldwide are affected by autoimmune disorders such as rheumatoid arthritis, psoriasis, multiple sclerosis, and many others. In autoimmune diseases, autoreactive T cells are considered as key players when acting as both regulatory and effector cells.

Based on the above, immunosuppressive biochemical pathways may become universal targets for immunotherapy in both human malignancies and autoimmune disorders. However, their targeting should lead to the opposite outcomes – downregulation in the case of cancer and activation in the case of autoimmunity.

The goal of this Research Topic is to provide recent advances in our understanding of the molecular and cellular mechanisms of anti-tumor immunity and autoimmune disease and, importantly, biochemical regulation and pharmacological correction of these immune networks.

We call for Original Research, Brief Research Reports, Reviews, Mini-Reviews, and Perspectives manuscripts that address the following topics:

• Recent advances in understanding the molecular mechanisms of anti-tumor immunity

• Novel findings related to tumour immune escape

• Novel approaches in anti-cancer immunotherapy

• Recent advances in understanding the mechanisms underlying autoimmune reactions

• Novel approaches for immunotherapy of autoimmune disease

• Key similarities and differences applicable to immunotherapy of cancer and autoimmune disease

• Pharmacological correction of immunosuppressive pathways

Download ebook

Share

Editors

Elizaveta Fasler-Kan

University Hospital of Bern

Vadim V Sumbayev

University of Kent

Bernhard F. Gibbs

Canterbury Christ Church University

Impact

36,725 Total views

24,371 Article views

11,318 Article downloads

1,036 Topic views

Published In

Journal Thumbnail

Frontiers in Medicine

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic